Email
Print
3D Printed Biosensors Market - Forecast(2024 - 2030)
3D Printed Biosensors Market Overview
The 3D Printed Biosensors Market size is
estimated to grow at a CAGR of 9.8% during the forecast period 2022-2027. 3D Printed
Biosensors are biosensing devices consisting of electrochemical, piezoelectric
and nanomechanical biosensors which are made from 3D printing technologies such
as material extrusion, vat photopolymerization and material jetting. The high-precision
nature and advanced quality analysis provided by 3D-printed biosensors are
driving their market demand. Major applications of 3D Printed Biosensors in
food processing, pathogen and toxicity detection are significantly influencing
their demand in the food & beverage, agriculture and medical & healthcare
sector. Factors such as government schemes to promote 3D printing in industrial
activities, an increase in usage of pesticides and the growing number of
diabetic patients are driving the market growth of 3D Printed Biosensors.
However, the costly nature of 3D printing is anticipated to pose a challenge in
the growth of the 3D Printed Biosensors industry, thereby affecting the 3D Printed Biosensors Market size. COVID-19 negatively impacted the 3D Printed Biosensors industry outlook as the lockdown restrictions decreased the demand
and usage of 3D Printed Biosensors for food processing and toxicity checking
applications in the food & beverage and agriculture sectors.
3D Printed Biosensors Market Report Coverage
The report: “3D Printed Biosensors Market Report –
Forecast (2022 – 2027)” by IndustryARC, covers an in-depth analysis of the
following segments in the 3D Printed Biosensors Industry.
Key Takeaways
- Asia-Pacific dominates the 3D Printed Biosensors industry, owing to the increasing prevalence of chronic diseases like diabetes in the region which is driving the demand for biosensors for diagnosing such diseases.
- The growing government initiatives to promote the usage of 3D printers for Industrial applications will create usage of 3D printers in medical applications, thereby positively impacting the 3D Printed Biosensors industry outlook
- The capital-intensive nature of 3D printing in comparison to manual manufacturing can affect its usage in making biosensors, thereby negatively impacting the 3D Printed Biosensors Market size.
Figure: Asia-Pacific 3D Printed Biosensors Market Revenue, 2021-2027 (US$ Million)
For more details on this report - Request for Sample
3D Printed Biosensors Market Segment Analysis – by Technology
The metal extrusion technology held
the largest share in the 3D Printed Biosensors Market share in 2021 and is
forecasted to grow at a CAGR of 9.7% during the forecast period 2022-2027.
Metal extrusion 3D printing in comparison to other printing techniques such as
material jetting and vat photopolymerization is more precise, subtle and
simple to use. Due to its low cost and simple usage, metal extrusion is also used
for prototyping different apparatuses for different medical fields. The
biosensors made in this manner have high applicability in biomedical fields
where they will be used for glucose detection and disease detection such as
diabetes, cardiovascular disease and cancer. Thus, owing to its advantageous
features and cost-effective nature, the demand for metal extrusion 3D printing
for biosensor applications is anticipated to rise during the forecast period,
thereby contributing to segment growth.
3D Printed Biosensor Market Segment Analysis – By End-Use Industry
The Medical & Healthcare sector
held the largest share in the 3D Printed Biosensors Market share in 2021 and is
forecasted to grow at a CAGR of 10.5% during the forecast period 2022-2027. 3D Printed Biosensors such as electrochemical, piezoelectric and nanomechanical are majorly
used in the medical & healthcare sector for the diagnosis and detection of
diabetes, cardiovascular disease and cancer. The number of cancer patients are
growing rapidly over the years on account of sedentary lifestyles and
environmental factors. For instance, according to the November 2021 statement
of the Indian Council of Medical Research, there will be a 12% increase in
cancer patients in the next five years. Furthermore, according to the American
Cancer Society, the number of new cancer cases is projected to reach 1.9
million in 2022, showing a massive jump in numbers from 2021. With the growing
number of cancer cases, the demand for 3D biosensors for diagnosis and detection
applications for cancer will also increase, thereby positively impacting the
market growth in the medical & healthcare sector during the forecast
period.
3D Printed Biosensors Market Segment Analysis – By Geography
Asia-Pacific held the largest share in the 3D Printed Biosensors Market share in 2021 up to 39%. The fuelling demand and growth of 3D Printed Biosensors such as electrochemical, nanomechanical and piezoelectric in the region is influenced by their major applicability in the medical & healthcare sector for disease detection. Major economies namely China, India and Japan are witnessing significant growth in the number of chronic diseases such as diabetes. For instance, according to the International Diabetes Federation report, in 2019, the prevalence of diabetes increased to 8.9% in India and 10.9% in China since 2009. Furthermore, the same report stated that the number of people with diabetes is forecasted to increase from 116 million to 140 million in China and from 77 million to 101 million in India by 2030. Having such high strength of diabetic patients will create demand for 3D Printed Biosensors for disease detection and diagnosis in India and China, thereby positively influencing the growth of the 3D Printed Biosensors industry in the Asia-Pacific region.
3D Printed Biosensors Market Drivers
Increase in Number of Diabetic Patients:
3D Printed Biosensors are used in the
medical field pervasively for detecting and diagnosing major chronic diseases
like diabetes. The number of
patients diagnosed with diabetes has increased over the years due to genetic
factors, environmental factors and insulin resistance. For instance, according
to National Diabetic Statistics Report by the Centre for Disease Control, in
2020, the cases of diabetes in the US had increased to 34.2 million.
Furthermore, according to International Diabetic Federation (IDF), in 2021,
approximately 537 million people worldwide were diagnosed with diabetes which
showed a 16% increase from 2019. With the increase in the number of diabetes
cases, the demand for 3D Printed Biosensors such as nanomechanical and
piezoelectric has also increased which has resulted in a positive growth of the 3D Printed Biosensors industry during the forecast period.
Government Schemes to Promote 3D Printing:
3D printing provides various benefits
such as flexible design, strong & lightweight parts, rapid prototyping,
minimizing waste and fast design & production. Seeing such benefits
governments are taking initiatives to promote the usage of the 3D printing
technique in industrial applications. For instance, the Biden Administration
May 2022, launched AM Forward Initiative to promote the use of 3D printing
technologies in industrial sectors. Furthermore, China’s Ministry of
Electronics and Information Technology, in December 2020, announced plans to
promote and increase the use of 3D printing technologies in China’s industries.
Such initiatives will create demand for 3D printing technologies in the medical
& healthcare sector for making biosensors for disease detection
applications, thereby positively impacting the growth of the 3D Printed Biosensors industry.
3D Printed Biosensors Market Challenge
High Cost Associated with 3D Printers:
Manually manufactured biosensors in
comparison to 3D Printed Biosensors are less costly as the materials required in
3D printers such as filaments are costly due to the extra processing they
require before their usage. Besides filaments usage of other expensive
materials such as resins, dye additives and powder materials like nylon also
increase the overall capital cost of 3D printers. Usage of such parts is
necessary for providing high-level printing of products and replacing them
would affect the functionality and performance of machines, thereby affecting
the product quality. The high cost associated with 3D printers will affect
their usage in making biosensors for the medical & healthcare, agriculture
and food & beverage sectors, thereby posing a challenge to the market
growth of 3D Printed Biosensors and affecting the 3D Printed Biosensors Market size.
3D Printed Biosensors Industry Outlook
Technology launches, acquisitions and
R&D activities are key strategies adopted by players in the 3D Printed Biosensors Market. The top 10 companies in 3D Printed Biosensors Market are:
- Allevi Inc.
- Advanced Solutions Life Science
- Cellink
- Cyfuse Biomedical
- Aspect Biosystem Ltd.
- OmniVision Technologies
- Nano3d Bioscience Inc.
- Digilab Inc
- Regenovo Biotechnology Co. Ltd.
- Organovo Holdings Inc.
Recent Developments
- In June 2022, the University of Houston created a revolutionary technique for 3D printing biosensors which consists of layer-by-layer polymerization of a resin filled with organic semiconductors to create tiny and biocompatible circuit boards.
- In June 2021, scientists at Weldon School of Biomedical Engineering created a 3D Printed Biosensor that will be able to detect critical regions in tissue and organs during surgical operations.
- In November 2020, scientists at Clarkson University developed a custom bio-ink that can be used to produce skin-compatible 3D printed wearable biosensors for sunburn protection.